| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/10/2002 | WO2001084140A3 Method and device for the qualitative and/or quantitative analysis of a protein and/or peptide pattern of a liquid sample that is derived from the human or animal body |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001079539A3 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
| 05/10/2002 | WO2001075141A3 Biosensor chip |
| 05/10/2002 | WO2001069260A3 A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001067102A3 Detection of chitin-containing contaminants such as microorganisms |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001059683A3 Integrated genomic services |
| 05/10/2002 | WO2001051620A3 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 05/10/2002 | WO2001048670A3 A method for the identification of gene transcripts with improved efficiency in the treatment of errors |
| 05/10/2002 | WO2001048468A3 Test device for testing long objects |
| 05/10/2002 | WO2001046420A3 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 05/10/2002 | WO2001044817A3 Fluorescence correlation spectroscopy to identify compound-target binding |
| 05/10/2002 | WO2001044499B1 Modified labeled complement components for immunoassays |
| 05/10/2002 | WO2001044496A3 Protease-activated receptor (par) modulator assays |
| 05/10/2002 | WO2001042795A3 Transferrin assay |
| 05/10/2002 | WO2001042781A3 Supracolonic aerodigestive neoplasm detection |
| 05/10/2002 | WO2001040466A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/10/2002 | WO2001038587A3 Energy-transfer assay for polynucleic acid polymerases |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001034849A9 Apparatus and method for disease detection |
| 05/10/2002 | WO2001034024A9 Marker detection method and apparatus to monitor drug compliance |
| 05/10/2002 | WO2001033199A3 Universal fluorescent sensors |
| 05/10/2002 | WO2001033190A3 Automated laser capture microdissection |
| 05/10/2002 | WO2001032930A9 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/10/2002 | WO2001028580A3 Modulation of angiogenesis |
| 05/10/2002 | WO2001027627A3 Assay device |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001026643A9 Inhibition of tumorigenic properties of melanoma cells |
| 05/10/2002 | WO2001025797A3 Methods of evaluating whether a test agent is an agent affecting a leptin receptor |
| 05/10/2002 | WO2001016359A3 Screen for axon viability |
| 05/10/2002 | WO2000079241A3 A system for cell-based screening |
| 05/10/2002 | WO2000075237A9 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000067736A3 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000055373A9 Methods of screening for macrophage development modulators |
| 05/10/2002 | WO2000046407A3 Methods of utilizing the tt virus |
| 05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 05/10/2002 | CA2464232A1 Sterol glucoside toxins |
| 05/10/2002 | CA2431332A1 Compositions and methods for prolonging survival of chilled platelets |
| 05/10/2002 | CA2428062A1 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
| 05/10/2002 | CA2428023A1 Methods and compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427747A1 Affinity maturation by competitive selection |
| 05/10/2002 | CA2427659A1 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | CA2427641A1 A method to determine an engrafting cell dose of hematopoietic stem celltransplant units |
| 05/10/2002 | CA2427604A1 Means for detecting pathological transformation of the app protein and their uses |
| 05/10/2002 | CA2427602A1 Detection of infectious agents using antigen mimics |
| 05/10/2002 | CA2427523A1 Predicting agent for metastasis |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427474A1 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427351A1 Method for analyzing proteins |
| 05/10/2002 | CA2427267A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | CA2427214A1 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | CA2427004A1 Method of diagnosing a transmissible spongiform encephalopathy |
| 05/10/2002 | CA2426658A1 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | CA2426571A1 Detection of ovarian cancer |
| 05/10/2002 | CA2426446A1 Detection of binding species with colloidal and non-colloidal structures |
| 05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | CA2396547A1 Diagnostic agent kit of schizophrenia |
| 05/10/2002 | CA2388548A1 System, method, and computer software product for linked window interfaces |
| 05/10/2002 | CA2361460A1 Method for performing wedge analysis for assessing wedge instabilities in underground openings |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020056146 Expression vector for use in generation of trangenic animals; for use in animal modeling of disease |
| 05/09/2002 | US20020056144 Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) |
| 05/09/2002 | US20020055689 Biopsy needle instrument |
| 05/09/2002 | US20020055667 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055524 Novel aryl substituted tetrahydroindazoles as ligands of the GABA receptor |
| 05/09/2002 | US20020055515 Contacting stimulated cells with a candidate compound which is an inhibitor of ATP binding to a P2Y- purinoceptor; and assaying said cells for release of one or more mediators. |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055478 Monitoring 103P3E8 gene products in a biological sample from a patient who has or who is suspected of having cancer and comparing the gene expression products with that of a normal sample |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055419 System and method to improve fitness training |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055188 Agglutination assay method and element in dry system |
| 05/09/2002 | US20020055186 Determining the presence of preferential proteins in sample; obtain sample containing protein, segment proteins, incubate sample with microarray of antibodies, detect bound amino acid sequences |
| 05/09/2002 | US20020055184 Apparatus for the detection of carbohydrate defective isoforms of transferrin |
| 05/09/2002 | US20020055182 Method for determining the fertility of mammals, especially humans |
| 05/09/2002 | US20020055181 Light generating compound for use in the detection of preferential particles in sample |
| 05/09/2002 | US20020055180 Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains |
| 05/09/2002 | US20020055178 Device for testing blood, immunohistochemical, serological, immunological and urinalysis samples |
| 05/09/2002 | US20020055176 Detection of preferenntial compounds in sample; obtain kit, insert sample, analyze for preferential compounds, display results on network |
| 05/09/2002 | US20020055166 Apparatus for use in propagating preferential culture; for use in the analysis of metabolic products and cells |
| 05/09/2002 | US20020055163 Amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides; useful in the development of human therapeutics and diagnostic formulations |
| 05/09/2002 | US20020055146 Control of the expression of anchored genes using micron scale heaters |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |